Nuveen Asset Management LLC Sells 75,704 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Nuveen Asset Management LLC trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,434,561 shares of the medical equipment provider's stock after selling 75,704 shares during the quarter. Intuitive Surgical makes up approximately 0.5% of Nuveen Asset Management LLC's portfolio, making the stock its 28th biggest holding. Nuveen Asset Management LLC owned approximately 0.96% of Intuitive Surgical worth $1,792,703,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Brookstone Capital Management increased its position in shares of Intuitive Surgical by 25.4% in the fourth quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider's stock worth $9,448,000 after purchasing an additional 3,663 shares during the last quarter. Capital Investment Advisors LLC increased its position in shares of Intuitive Surgical by 15.6% in the fourth quarter. Capital Investment Advisors LLC now owns 899 shares of the medical equipment provider's stock worth $469,000 after purchasing an additional 121 shares during the last quarter. Fragasso Financial Advisors Inc increased its position in shares of Intuitive Surgical by 3.0% in the fourth quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider's stock worth $359,000 after purchasing an additional 20 shares during the last quarter. Cooper Financial Group increased its position in shares of Intuitive Surgical by 23.4% in the fourth quarter. Cooper Financial Group now owns 1,059 shares of the medical equipment provider's stock worth $553,000 after purchasing an additional 201 shares during the last quarter. Finally, Claro Advisors LLC increased its position in shares of Intuitive Surgical by 3.1% in the fourth quarter. Claro Advisors LLC now owns 1,250 shares of the medical equipment provider's stock worth $652,000 after purchasing an additional 37 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on ISRG shares. Royal Bank of Canada decreased their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Finally, Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $598.95.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company's stock, valued at approximately $2,793,033.06. The trade was a 60.72% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 32,700 shares of company stock valued at $16,865,621 in the last quarter. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

Shares of ISRG traded up $3.32 during trading hours on Friday, hitting $563.60. The company had a trading volume of 1,422,176 shares, compared to its average volume of 1,644,552. The firm has a fifty day moving average price of $505.22 and a 200-day moving average price of $536.61. The stock has a market capitalization of $202.00 billion, a price-to-earnings ratio of 87.93, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 52-week low of $395.60 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the previous year, the firm earned $1.50 EPS. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.